Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AssetMark Financial | AMK | Aug 30, 2024 | 35.15 | +0.20 |
Associated Banc E Pref | ASB-E | Aug 30, 2024 | 22.84 | -0.31 |
Associated Banc-Corp F Pref | ASB-F | Aug 30, 2024 | 21.92 | +0.32 |
Associated Bancorp | ASB | Aug 30, 2024 | 22.88 | +0.75 |
Associated Capital Group | AC | Aug 30, 2024 | 33.33 | +0.03 |
Assurant | AIZ | Aug 30, 2024 | 196.35 | +0.51 |
Assured Guaranty | AGO | Aug 30, 2024 | 80.08 | +0.48 |
AST SpaceMobile A | ASTS | Aug 30, 2024 | 29.04 | -0.72 |
Astec Industries | ASTE | Aug 30, 2024 | 33.83 | -0.44 |
Astera Labs | ALAB | Aug 30, 2024 | 43.06 | -10.70 |
Astrana Health | ASTH | Aug 30, 2024 | 47.79 | +0.50 |
AstraZeneca ADR | AZN | Aug 30, 2024 | 87.62 | +0.37 |
Astria Therapeutics | ATXS | Aug 30, 2024 | 12.23 | +1.75 |
Astronics | ATRO | Aug 30, 2024 | 22.42 | +0.67 |
AstroNova | ALOT | Aug 30, 2024 | 14.89 | +0.27 |
Astrotech | ASTC | Aug 30, 2024 | 11.24 | +2.00 |
Asure Software | ASUR | Aug 30, 2024 | 8.59 | -0.58 |
AT&T | T | Aug 30, 2024 | 19.90 | +0.71 |
AT&T A Pref | T-A | Aug 30, 2024 | 21.86 | -1.40 |
AT&T C Pref | T-C | Aug 30, 2024 | 20.77 | -0.81 |
ATA Creativity Global ADR | AACG | Aug 30, 2024 | 0.59 | -0.92 |
Atai Life Sciences BV | ATAI | Aug 30, 2024 | 1.30 | 0.00 |
Atara Biotherapeutics | ATRA | Aug 30, 2024 | 7.60 | +7.65 |
Atea Pharmaceuticals | AVIR | Aug 30, 2024 | 3.85 | +1.85 |
Aterian | ATER | Aug 30, 2024 | 2.99 | +1.01 |
Athena Technology Acquisition II | ATEK | Aug 30, 2024 | 11.46 | +0.26 |
Athene A Pref | ATH-A | Aug 30, 2024 | 24.85 | -1.31 |
Athene B Pref | ATH-B | Aug 30, 2024 | 22.41 | -0.93 |
Athene C Pref | ATH-C | Aug 30, 2024 | 25.14 | -0.16 |
Athene D Pref | ATH-D | Aug 30, 2024 | 19.20 | -0.78 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.